Bahl & Gaynor Inc. increased its holdings in Colgate-Palmolive Company (NYSE:CL) by 4.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,134 shares of the company’s stock after purchasing an additional 1,593 shares during the quarter. Bahl & Gaynor Inc.’s holdings in Colgate-Palmolive were worth $2,561,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. First Eagle Investment Management LLC raised its holdings in shares of Colgate-Palmolive by 2.3% during the second quarter. First Eagle Investment Management LLC now owns 4,891,131 shares of the company’s stock valued at $362,580,000 after acquiring an additional 108,850 shares during the period. TIAA CREF Investment Management LLC raised its holdings in shares of Colgate-Palmolive by 3.7% during the second quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock valued at $350,267,000 after acquiring an additional 170,053 shares during the period. Fiera Capital Corp raised its holdings in shares of Colgate-Palmolive by 17.3% during the second quarter. Fiera Capital Corp now owns 4,595,453 shares of the company’s stock valued at $340,662,000 after acquiring an additional 677,657 shares during the period. Legal & General Group Plc raised its holdings in shares of Colgate-Palmolive by 2.2% during the second quarter. Legal & General Group Plc now owns 4,390,317 shares of the company’s stock valued at $325,461,000 after acquiring an additional 96,427 shares during the period. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of Colgate-Palmolive by 1.2% during the first quarter. Schwab Charles Investment Management Inc. now owns 3,474,194 shares of the company’s stock valued at $254,277,000 after acquiring an additional 39,843 shares during the period. Institutional investors and hedge funds own 73.87% of the company’s stock.
Shares of Colgate-Palmolive Company (NYSE CL) opened at $71.89 on Friday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The company has a market cap of $63,126.96, a P/E ratio of 25.05, a price-to-earnings-growth ratio of 3.29 and a beta of 0.80. Colgate-Palmolive Company has a 1 year low of $63.43 and a 1 year high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The company had revenue of $3.97 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.73 earnings per share. sell-side analysts predict that Colgate-Palmolive Company will post 2.88 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.23%. The ex-dividend date was Friday, October 20th. Colgate-Palmolive’s dividend payout ratio is 61.78%.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the sale, the director now directly owns 36,268 shares of the company’s stock, valued at $2,557,619.36. The disclosure for this sale can be found here. Insiders sold 173,673 shares of company stock valued at $12,629,293 over the last three months. Insiders own 1.02% of the company’s stock.
A number of equities research analysts have recently issued reports on the stock. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, October 17th. Jefferies Group LLC restated a “hold” rating and set a $79.00 price target (up previously from $77.00) on shares of Colgate-Palmolive in a report on Monday, July 24th. Deutsche Bank AG restated a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a report on Monday, July 24th. Finally, Wells Fargo & Company restated a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the stock. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $76.67.
TRADEMARK VIOLATION WARNING: This piece was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://stocknewstimes.com/2017/11/19/bahl-gaynor-inc-grows-position-in-colgate-palmolive-company-cl.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.